Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Fingolimod (FTY720): First approved oral therapy for multiple sclerosis.
2011
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
September 2006, The New England journal of medicine,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).
September 2011, Discovery medicine,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
FTY720 (fingolimod) for relapsing multiple sclerosis.
May 2008, Expert review of neurotherapeutics,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
January 2010, Clinical neuropharmacology,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis.
July 2011, Journal of pharmacology & pharmacotherapeutics,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Oral therapy approved for multiple sclerosis.
May 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
April 2011, Journal of natural products,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
[FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
October 2007, Der Nervenarzt,
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
February 2010, Multiple sclerosis (Houndmills, Basingstoke, England),
Sushil Sharma, and A G Mathur, and Sapna Pradhan, and D B Singh, and Sparsh Gupta
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.
November 2010, Nature reviews. Drug discovery,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name